24/7
Buzz
Startups
VC
AI
Innovation
Opinions
Events
Promising Startups 2022
BiblioTech
Boarding Pass
Corporate
Appointments
CTalk
Tech Gateways
2022 VC Survey
@Finance
Ctech Testimonials
Shopping
Projects
About
Newsletter
Contact us
RSS
Facebook
Twitter
ACCESSIBILITY
by
Homepage
Rimsa
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
Innovation
OPINIONS
EVENTS
SHOPPING
ABOUT
Terms Of Use
Privacy Policy
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
21:40
Florida enthusiastically welcomes Calcalist conference to Miami
18:24
Bitsight acquires Cybersixgill in $115 million deal to strengthen cyber risk management
16:04
Full list of Israeli startup M&As in 2024
16:00
Immunai and Teva launch multi-tear AI collaboration for smarter drug development
More stories
Buzz
Most popular
Daily
Weekly
1
Oracle CEO: "If we continue on our current trajectory, reaching a valuation of a trillion dollars is inevitable"
2
Is your solitaire opponent actually a bot?
3
Cloudera acquires Israeli startup Octopai to advance metadata and AI integration
4
Former Snyk founder Guy Podjarny secures $125M for AI-powered software startup Tessl
5
CyberArk and Wiz join forces to enhance cloud security in multi-cloud environments
More news
Rimsa
3 stories about Rimsa
Israeli court documents reveal worrying details on Teva’s decision to acquire Mexico’s Rimsa
08.06.20
|
Sophie Shulman
Classified documents show that Teva's board of directors didn't even dedicate a full meeting to the acquisition
Derivative Suit Sheds Light on Teva’s Disastrous Rimsa Acquisition
28.05.19
|
Hezi Sternlicht
Teva acquired Mexican drugmaker Rimsa in 2016, but an anonymous email sent a week after the deal’s completion led Teva to launch an internal investigation—and sue the sellers for fraud
Teva and Rimsa Settle Contested $2.3-Billion Acquisition Deal Out of Court
10.04.18
|
Dror Reich
Teva acquired the Mexican plant in 2016 but shut it down immediately, citing discrepancies between Rimsa's regulatory filing and the actual assets, and filed a suit against the former owners
Please ensure Javascript is enabled for purposes of
website accessibility